Status:
WITHDRAWN
Opioid-free Total Hip Arthroplasty
Lead Sponsor:
Johns Hopkins University
Conditions:
Hip Osteoarthritis
Eligibility:
All Genders
Phase:
NA
Brief Summary
The primary objective of investigators' proposed study is to demonstrate that the following two cohorts undergoing total hip arthroplasty will have equivalent visual analog scale (VAS) scores up to 3 ...
Eligibility Criteria
Inclusion
- Patients of all ages with end-stage primary hip osteoarthritis.
Exclusion
- Patients with creatinine clearance between 30 and 60 mL/min
- Use of any opioid analgesics in the 6 months preceding surgery
- Revision total hip arthroplasty
- Patients with liver insufficiency
- Patients on chronic anticoagulation
- Workers compensation patients
- Patients who cannot receive Acetaminophen, Ketorolac, Celecoxib, or Gabapentin for any reason (e.g. allergies)
Key Trial Info
Start Date :
September 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04421196
Start Date
September 15 2022
End Date
December 1 2023
Last Update
September 21 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.